Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — AMBA

Balance Sheet

(in millions USD)

Metric	Q2 2027	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	101.85	114.44	191.02	174.06	142.74	144.62	127.12	153.93	141.29	144.91	143.79	122.52	127.74	113.54	112.84	194.94	200.64	171.04	457.76	258.40
Accounts Receivable	37.44	39.17	39.18	42.23	42.90	29.77	33.97	23.16	30.24	24.95	22.97	30.16	29.83	51.99	48.56	37.70	28.01	44.31	44.78	38.30
Inventory	76.92	80.36	52.25	39.16	33.81	34.43	36.59	30.66	39.29	29.04	30.78	34.77	41.22	40.49	45.40	40.10	41.52	45.22	47.04	42.08
Total Current Assets	394.02	405.19	410.28	383.67	343.87	320.55	303.61	279.68	335.55	280.16	279.82	286.65	304.52	304.63	298.33	282.86	278.33	266.75	555.37	534.02
Property, Plant & Equipment	12.06	12.59	11.55	10.73	10.09	9.08	9.68	9.04	10.25	10.44	10.92	11.25	11.28	11.81	10.75	10.44	10.14	10.13	8.50	8.24
Goodwill	303.63	303.63	303.63	303.63	3.50	303.63	303.63	303.63	303.63	303.63	303.63	303.63	303.63	303.63	303.63	303.63	303.63	303.63	26.60	26.60
Intangible Assets	56.67	59.02	58.05	37.95	41.88	47.28	44.96	48.40	44.90	55.14	58.81	63.12	55.54	58.50	47.55	49.56	48.48	46.30	15.27	15.80
Total Non-current Assets*	386.18	389.65	388.33	368.22	362.56	368.42	367.18	370.65	366.37	377.50	404.81	409.60	400.26	405.56	389.13	391.56	390.34	390.80	77.98	76.04
Total Assets	780.21	794.84	798.60	751.89	706.43	688.97	670.79	650.33	701.92	657.66	684.63	696.24	704.78	710.20	687.46	674.42	668.67	657.55	633.36	610.06
Accounts Payable	26.48	53.28	54.03	34.92	26.78	21.78	25.23	19.44	35.29	28.50	9.30	11.94	25.63	17.85	29.13	22.07	29.76	31.17	27.07	33.12
Total Current Liabilities	138.37	166.96	177.94	144.45	125.94	120.99	106.87	91.46	124.85	82.98	75.83	74.69	80.15	83.46	80.93	77.54	74.86	89.28	81.62	85.54
Total Non-current Liabilities*	21.52	22.06	25.87	17.32	3.97	6.56	9.62	11.33	4.35	14.81	17.01	19.24	18.44	20.65	18.13	18.77	19.46	21.09	22.50	21.47
Total Liabilities	159.89	189.02	203.81	161.78	129.91	127.56	116.49	102.78	129.20	97.78	92.84	93.93	98.59	104.11	99.06	96.31	94.32	110.37	104.12	107.00
Retained Earnings	(352.70)	(346.01)	(327.92)	(311.49)	(296.38)	(252.06)	(231.82)	(207.75)	(276.38)	(134.93)	(74.32)	(32.61)	(1.42)	34.49	45.59	65.40	89.05	99.87	109.07	108.31
Total Stockholder Equity	620.32	605.82	594.79	590.11	576.52	561.41	554.29	547.55	572.72	559.87	591.79	602.32	606.19	606.09	588.40	578.11	574.35	547.18	529.24	503.05

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2027	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Total Revenue	108.13	100.36	100.87	108.45	95.51	84.02	82.65	63.72	85.87	51.62	50.60	62.12	62.14	83.32	83.10	80.88	90.31	90.23	92.17	79.33
Cost of Revenue	45.71	41.77	41.95	43.87	39.28	33.63	32.60	24.98	34.34	20.76	20.61	23.66	24.62	33.68	31.42	29.82	33.76	32.91	34.54	29.91
Gross Profit	62.42	58.59	58.91	64.59	56.23	50.38	50.05	38.74	51.54	30.85	29.98	38.46	37.52	49.65	51.68	51.06	56.55	57.32	57.63	49.42
Research & Development	50.58	58.14	58.52	61.45	59.73	56.82	58.39	56.76	58.82	51.99	53.70	54.92	54.44	53.05	52.86	52.34	46.69	48.54	41.36	39.56
Selling, General & Admin	19.98	19.86	18.83	19.38	18.49	18.91	17.17	18.27	18.58	20.58	18.25	18.88	18.62	20.03	18.94	18.91	20.36	21.12	17.48	15.82
Total Operating Expenses	70.56	78.01	77.35	80.83	78.22	75.73	75.56	75.03	77.39	72.57	71.95	73.80	73.06	73.08	71.81	71.25	67.05	69.66	58.84	55.38
Operating Income	(8.14)	(19.42)	(18.43)	(16.25)	(21.99)	(25.35)	(25.51)	(36.29)	(25.86)	(41.71)	(41.96)	(35.34)	(35.54)	(23.44)	(20.13)	(20.19)	(10.50)	(12.34)	(1.21)	(5.96)
Pretax Income	(6.34)	(17.33)	(16.10)	(14.17)	(19.74)	(22.99)	(23.42)	(34.14)	(23.68)	(39.61)	(40.06)	(34.60)	(34.26)	(21.61)	(18.70)	(20.21)	(10.41)	(12.55)	(0.80)	(5.74)
Tax Provision	0.35	0.76	0.34	0.93	0.25	(2.76)	0.65	0.75	0.65	21.00	1.65	(3.40)	1.65	(10.51)	1.11	3.44	0.41	(3.36)	(1.56)	1.41
Net Income	(6.69)	(18.09)	(16.43)	(15.11)	(19.99)	(20.23)	(24.07)	(34.89)	(24.33)	(60.61)	(41.71)	(31.20)	(35.90)	(11.10)	(19.81)	(23.65)	(10.82)	(9.19)	0.76	(7.16)
Basic EPS	(0.15)	(0.41)	(0.38)	(0.35)	(0.47)	(0.48)	(0.58)	(0.85)	(0.58)	(1.51)	(1.04)	(0.79)	(0.91)	(0.28)	(0.51)	(0.62)	(0.29)	(0.24)	0.02	(0.20)
Diluted EPS	(0.15)	(0.41)	(0.38)	(0.35)	(0.47)	(0.48)	(0.58)	(0.85)	(0.58)	(1.51)	(1.04)	(0.79)	(0.91)	(0.28)	(0.51)	(0.62)	(0.29)	(0.24)	0.02	(0.20)

← Scroll for more columns →

Cash Flow Statement

(in millions USD)

Metric	Q2 2027	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Cash Flow	(0.26)	(25.63)	18.90	34.31	20.31	25.43	6.62	(13.01)	14.80	(4.03)	7.87	(6.84)	22.03	5.09	6.00	(0.56)	33.56	20.57	8.33	14.44
Capital Expenditures	6.82	3.96	3.92	2.90	8.69	4.18	2.50	(0.87)	4.57	1.93	2.35	5.40	2.30	2.03	4.93	3.39	4.70	3.44	2.48	1.80
Free Cash Flow*	(7.08)	(29.58)	14.97	31.41	11.62	21.25	4.12	(12.14)	10.24	(5.96)	5.52	(12.23)	19.73	3.06	1.07	(3.94)	28.86	17.13	5.85	12.64
Investing Cash Flow	(14.65)	(46.29)	(4.39)	(5.00)	(21.10)	(10.47)	(35.82)	21.91	(16.15)	2.79	13.02	0.24	(8.21)	(8.14)	(88.85)	(6.36)	(3.95)	(310.48)	188.02	14.14
Financing Cash Flow	2.32	(4.66)	2.46	2.01	(0.66)	2.54	2.40	3.02	(1.55)	2.37	0.38	1.37	0.39	3.75	0.74	1.22	(0.01)	3.19	3.00	2.32

← Scroll for more columns →

* Derived from reported values